CA26342-2 - 0x0000000000003B7A

Males & Females of Non-Childbearing Potential

Quick

* Stipend may pay up to reflected amount.
Start Date: 
March 6, 2019 - 3:00pm
End Date: 
March 24, 2019 - 9:00am
Study Number: CA26342
Group Number: 2
Study Requirement: Healthy Male and Female
Stipend: $2,315.00

Study Criteria:

  • Age: 19 - 55
  • BMI: 18 - 32
  • Weight Restriction: minimum weight 0 lbs

Study Information:

  • Indication: This investigational medication is being developed to treat Cystic Fibrosis.
  • Route of Administration: Oral
  • Blood Draws: 15

Study Schedule:

  • Schedule Type: Short stays with returns
  • Study Length: Two - 2 Night Stays, 2 - Returns & 4 Phone Calls

Screening Dates:

Event Day Event Date Site
Tuesday 2/19/2019 Lincoln
Friday 2/22/2019 Lincoln

Doctor Exam Dates:

Event Day Event Date Site
Tuesday 2/19/2019 Lincoln
Friday 2/22/2019 Lincoln

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Check-In Wednesday 3/6/2019 3:00:00 PM Friday 3/8/2019 5:30:00 PM 1 Lincoln
Return Sunday 3/10/2019 9:00:00 AM Sunday 3/10/2019 10:00:00 AM 1 Lincoln
Phone participant* Thursday 3/14/2019 1:00:00 PM 1 Lincoln
Check-In Wednesday 3/20/2019 3:00:00 PM Friday 3/22/2019 5:30:00 PM 2 Lincoln
Phone participant* Thursday 3/21/2019 1:00:00 PM 1 Lincoln
Return Sunday 3/24/2019 8:00:00 AM Sunday 3/24/2019 9:00:00 AM 2 Lincoln
Phone participant* Thursday 3/28/2019 12:00:00 PM 2 Lincoln
Phone participant* Thursday 4/4/2019 12:00:00 PM 2 Lincoln